| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.22 | 4e-12 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.19 | 5e-10 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-09 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-09 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.19 | 3e-09 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.18 | 1e-08 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.18 | 2e-08 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.17 | 3e-08 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.17 | 5e-08 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.16 | 5e-08 |